Keyphrases
Tyrosine Kinase Inhibitor
100%
Virtual Screening
100%
Tyrosine Kinase Domain
100%
High-throughput
50%
Cell-free
50%
Targeted Therapy
50%
Small Molecule Inhibitors
50%
Tumor Progression
50%
Tumor Metastasis
50%
Intact Cells
50%
Dysregulated
50%
Tumorigenesis
50%
In Silico
50%
Free Cells
50%
IC50 Value
50%
Binding Mode
50%
Active Compounds
50%
Normal Development
50%
Kinase Domain
50%
Binding Residues
50%
Cancer Types
50%
Cell-based Assay
50%
Hepatocyte Growth Factor
50%
Inactive Conformation
50%
Normal Homeostasis
50%
ATP Binding Site
50%
Human Malignancies
50%
Hepatocyte Growth Factor Receptor
50%
Binding Targets
50%
Biological Screening
50%
Mode Selectivity
50%
Target Selectivity
50%
Virtual Screen
50%
Tyrosine Kinase Oncogene
50%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase Inhibitor
100%
Tyrosine Kinase
100%
Binding Site
100%
Receptor Tyrosine Kinase
100%
Hepatocyte Growth Factor
100%
Small Molecule
50%
Conformation
50%
Tyrosine
50%
Development
50%
Homeostasis
50%
IC50
50%
Cell Assay
50%
Adenosine Triphosphate
50%
Growth Factor Receptor
50%
Phosphotransferase
50%
Kinase
50%
Carcinogenesis
50%
Tumor Progression
50%
Medicine and Dentistry
Virtual Screening
100%
Protein Tyrosine Kinase
100%
Tyrosine-Kinase Inhibitor
100%
Binding Site
100%
Development
50%
Phosphotransferase
50%
Cancer
50%
Tumor Progression
50%
Targeted Therapy
50%
Metastatic Carcinoma
50%
Homeostasis
50%
Carcinogenesis
50%
In Silico
50%
Cancer Types
50%
Scatter Factor
50%
Scatter Factor Receptor
50%
Adenosine Triphosphate
50%
IC50
50%
Pharmacology, Toxicology and Pharmaceutical Science
Virtual Screening
100%
Protein Tyrosine Kinase Inhibitor
100%
Binding Site
100%
Protein Tyrosine Kinase
100%
Malignant Neoplasm
50%
Metastasis
50%
Tumor Growth
50%
Phosphotransferase
50%
Scatter Factor
50%
Scatter Factor Receptor
50%
IC50
50%
Adenosine Triphosphate
50%
Carcinogenesis
50%